Table 4 In situ expression of miR-375 in small intestinal neuroendocrine tumors analyzed on tissue microarray

From: miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival

Score

Primary tumors no. (%)

Lymph node metastases no. (%)

Liver metastases no. (%)

Distant metastases no. (%)

All sites no.

0

22 (7.9)

21 (8.8)

9 (12.2)

5 (12.0)

57

1

63 (22.6)

70 (25.1)

23 (31.1)

11 (26.2)

167

2

107 (38.4)

96 (40.0)

22 (29.7)

17 (40.5)

242

3

87 (31.2)

53 (22.1)

20 (27.0)

9 (21.4)

169

Total

279

240

74

42

635